In this issue:
Occult HBV infection: high risk for HCC
Interferon first-line in HbeAg positive CHB?
Elastography-based assessment of liver stiffness
HCC prevention a cost-effective strategy?
HBV vax: immunogenicity in haemodialysis patients
PROVE I: telaprevir in chronic genotype 1 HCV
PROVE II: telaprevir in chronic genotype 1 HCV
Body weight predicts neutropenia on PEG-IFN
HCV G1b a risk factor for HCC
Psychosocial issues in hepatitis C
Please login below to download this issue (PDF)